These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23221122)

  • 41. When information is not power: Community-elected health facility committees and health facility performance indicators.
    Falisse JB; Ntakarutimana L
    Soc Sci Med; 2020 Nov; 265():113331. PubMed ID: 32905968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring payment schemes used to promote integrated chronic care in Europe.
    Tsiachristas A; Dikkers C; Boland MR; Rutten-van Mölken MP
    Health Policy; 2013 Dec; 113(3):296-304. PubMed ID: 23937868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Institutional design and organizational practice for universal coverage in lesser-developed countries: challenges facing the Lao PDR.
    Ahmed S; Annear PL; Phonvisay B; Phommavong C; Cruz Vde O; Hammerich A; Jacobs B
    Soc Sci Med; 2013 Nov; 96():250-7. PubMed ID: 23433544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An equity analysis of performance-based financing in Rwanda: are services reaching the poorest women?
    Priedeman Skiles M; Curtis SL; Basinga P; Angeles G
    Health Policy Plan; 2013 Dec; 28(8):825-37. PubMed ID: 23221121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Additional cash incentive within a conditional cash transfer scheme: a 'controlled before and during' design evaluation study from India.
    Lahariya C; Mishra A; Nandan D; Gautam P; Gupta S
    Indian J Public Health; 2011; 55(2):115-20. PubMed ID: 21941046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Looking into the performance-based financing black box: evidence from an impact evaluation in the health sector in Cameroon.
    de Walque D; Robyn PJ; Saidou H; Sorgho G; Steenland M
    Health Policy Plan; 2021 Jun; 36(6):835-847. PubMed ID: 33963406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How is the discourse of performance-based financing shaped at the global level? A poststructural analysis.
    Gautier L; De Allegri M; Ridde V
    Global Health; 2019 Jan; 15(1):6. PubMed ID: 30646933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The sudden removal of user fees: the perspective of a frontline manager in Burundi.
    Nimpagaritse M; Bertone MP
    Health Policy Plan; 2011 Nov; 26 Suppl 2():ii63-71. PubMed ID: 22027921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pay-for-performance as a method to establish the business case for quality.
    Wheeler JR; White B; Rauscher S; Nahra TA; Reiter KL; Curtin KM; Damberg CL
    J Health Care Finance; 2007; 33(4):17-30. PubMed ID: 19172960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality-based purchasing in health care.
    Waters HR; Morlock LL; Hatt L
    Int J Health Plann Manage; 2004; 19(4):365-81. PubMed ID: 15688878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Financial incentives and the health workforce.
    Scott A; Connelly LB
    Aust Health Rev; 2011 Aug; 35(3):273-7. PubMed ID: 21871186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving health worker performance: The patient-perspective from a PBF program in Rwanda.
    Lannes L
    Soc Sci Med; 2015 Aug; 138():1-11. PubMed ID: 26026400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From Amsterdam to Bamako: a qualitative case study on diffusion entrepreneurs' contribution to performance-based financing propagation in Mali.
    Gautier L; Coulibaly A; De Allegri M; Ridde V
    Health Policy Plan; 2019 Nov; 34(9):656-666. PubMed ID: 31529035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control and performance of health care systems. A comparative analysis of 19 OECD countries.
    Kotzian P
    Int J Health Plann Manage; 2008; 23(3):235-57. PubMed ID: 18536004
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How do performance-based financing programmes measure quality of care? A descriptive analysis of 68 quality checklists from 28 low- and middle-income countries.
    Josephson E; Gergen J; Coe M; Ski S; Madhavan S; Bauhoff S
    Health Policy Plan; 2017 Oct; 32(8):1120-1126. PubMed ID: 28549142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What is the empirical basis for paying for quality in health care?
    Rosenthal MB; Frank RG
    Med Care Res Rev; 2006 Apr; 63(2):135-57. PubMed ID: 16595409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 10 best resources on ... pay for performance in low- and middle-income countries.
    Honda A
    Health Policy Plan; 2013 Aug; 28(5):454-7. PubMed ID: 22962058
    [No Abstract]   [Full Text] [Related]  

  • 58. Payment mechanisms, nonprice incentives, and organizational innovation in health care.
    Robinson JC
    Inquiry; 1993; 30(3):328-33. PubMed ID: 8406788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The performance management system: applying and evaluating a pay-for-performance initiative.
    Helm C; Holladay CL; Tortorella FR
    J Healthc Manag; 2007; 52(1):49-62; discussion 62-3. PubMed ID: 17288117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative health systems: a conceptual framework.
    McManus SM; Thai KV
    J Health Hum Serv Adm; 1998; 20(4):520-36. PubMed ID: 10338724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.